Article

[Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].

Klinik und Poliklinik für Allgemein- und Abdominalchirurgie, Johannes-Gutenberg-Universität Mainz.
Der Chirurg (impact factor: 0.7). 11/2003; 74(10):922-30; discussion 929-30. DOI:10.1007/s00104-003-0711-x pp.922-30; discussion 929-30
Source: PubMed

ABSTRACT Exact preoperative staging is a prerequisite for the indication and the choice of appropriate operative technique for patients with esophageal carcinoma. The objective of this prospective study was to assess whether positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) increases the accuracy of preoperative lymph node staging with standard computed tomography (CT) and thus leads to a different surgical approach.
Fifty-eight patients with carcinoma of the esophagus (46 men and 12 women) with a median age of 61 years underwent FDG-PET imaging of the neck, chest, and abdomen as well as CT of the chest and abdomen. Sensitivity, specificity, and accuracy were calculated for both imaging techniques to evaluate the detection of histologically verified lymph node metastases.
The FDG-PET showed higher specificity, whereas CT proved to be more accurate for detecting lymph node metastases not only of the abdomen (73% vs 59%) but also of the thorax (73% vs 63%). Resections were transhiatal in 23 patients and transthoracal in 16. As a supplement to conventional CT diagnostic procedure, FDG-PET was not decisive for the surgical approach.
Altogether, pretherapeutical PET imaging did not increase the accuracy of lymph node staging for our patients with esophageal carcinoma, which had already been defined through CT. Therefore, no new consequences resulted for the surgical procedure. Due to the high costs involved with PET investigation, lymph node staging with it is momentarily indicated mainly for clinical studies and when CT does not offer unequivocal results. Increased sensitivity of the already advantageous whole-body FDG-PET imaging by means of tumor-affinitive radiopharmaceuticals and optimized apparatus resolution could lead to new indications for this staging procedure.

0 0
 · 
0 Bookmarks
 · 
29 Views
  • Source
    Article: Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.
    [show abstract] [hide abstract]
    ABSTRACT: In an era in which it is possible to deliver radiation with high precision, there is a heightened need for enhanced imaging capabilities to improve tumour localisation for diagnostic, planning and delivery purposes. This is necessary to increase the accuracy and overall efficacy of all types of external beam radiotherapy (RT), including particle therapies. Positron emission tomography (PET) has the potential to fulfil this need by imaging fundamental aspects of tumour biology. The key areas in which PET may support the RT process include improving disease diagnosis and staging; assisting tumour volume delineation; defining tumour phenotype or biological tumour volume; assessment of treatment response; and in-beam monitoring of radiation dosimetry. The role of PET and its current developmental status in these key areas are overviewed in this review, highlighting the advantages and drawbacks.
    The British journal of radiology 03/2011; 84 Spec No 1:S19-34. · 2.11 Impact Factor

Keywords

advantageous whole-body FDG-PET imaging
 
appropriate operative technique
 
conventional CT diagnostic procedure
 
detecting lymph node metastases
 
different surgical approach
 
Exact preoperative
 
FDG-PET
 
FDG-PET imaging
 
higher specificity
 
imaging techniques
 
lymph node metastases
 
new consequences
 
new indications
 
optimized apparatus resolution
 
PET investigation
 
preoperative lymph node
 
pretherapeutical PET imaging
 
prospective study
 
Resections
 
standard computed tomography